HC Wainwright assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON) in a report released on Thursday, August 29th, ...
Feeds
41727 items (41727 unread) in 74 feeds
Acinar Cell Carcinoma
(270 unread)
Acinic Cell Carcinoma
(199 unread)
Adenoid Cystic Carcinoma
(878 unread)
Adrenal Gland Cancer
(3518 unread)
Ampulla Of Vater
(1056 unread)
Anal Cancer
(4237 unread)
Angiosarcoma
(1305 unread)
Appendix Cancer
(565 unread)
Bile Duct Cancer
(5103 unread)
Brain and CNS
(5535 unread)
Carcinoid
(1785 unread)
Endocrine/Neuroendocrine
(4610 unread)
Gall Bladder Cancer
(1908 unread)
Hemangioendothelioma
(491 unread)
Hepatoblastoma
(611 unread)
Pancreas
(569 unread)
Phyllodes
(317 unread)
PMP and Mucinous Tumors
(387 unread)
Rhabdomyosarcoma
(1544 unread)
Sarcoma
(6839 unread)
Google - Angiosarcoma (100 unread)
-
TRACON Pharmaceuticals (NASDAQ:TCON) Research Coverage Started at HC Wainwright - Mayfield Recorder
Posted: September 14th, 2019, 6:46am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Research Coverage Started at HC Wainwright Mayfield Recorder -
Soft Tissue Sarcoma Treatment Market to Record an Exponential CAGR by 2025 - Herald Space
Posted: September 13th, 2019, 6:36pm GMT
Soft Tissue Sarcoma Treatment Market to Record an Exponential CAGR by 2025 Herald SpaceSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Cut to Sell at Zacks Investment Research - Mayfield Recorder
Posted: September 13th, 2019, 10:32am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Cut to Sell at Zacks Investment Research Mayfield RecorderZacks Investment Research lowered shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a hold rating to a sell rating in a research report released on ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and XOMA Corporation (NASDAQ:XOMA) - Stocks Beat
Posted: September 13th, 2019, 8:48am GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and XOMA Corporation (NASDAQ:XOMA) Stocks BeatBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and XOMA Corporation (NASDAQ:XOMA) are Biotechnology companies, competing one another. We will ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Precision BioSciences Inc. (NASDAQ:DTIL)'s results - Stocks Beat
Posted: September 13th, 2019, 1:45am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Precision BioSciences Inc. (NASDAQ:DTIL)'s results Stocks BeatBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Precision BioSciences Inc. (NASDAQ:DTIL) compete on a level playing field in the Biotechnology ...
-
TRACON Pharmaceuticals Inc. (TCON) and Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) Contrasting side by side - The EN Herald
Posted: September 12th, 2019, 3:27am GMT
TRACON Pharmaceuticals Inc. (TCON) and Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) Contrasting side by side The EN HeraldAs Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM), are affected by compare.
-
My Dad Was A 9/11 First Responder. Then A Giant Tumour Started Growing In His Chest. - HuffPost UK
Posted: September 11th, 2019, 1:43pm GMT
My Dad Was A 9/11 First Responder. Then A Giant Tumour Started Growing In His Chest. HuffPost UK9/11-related illnesses often make affected families feel like that dark day has never ended.
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Stock Is Buy After Less Market Selling - The MAK Daily
Posted: September 11th, 2019, 1:16pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Stock Is Buy After Less Market Selling The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
TRACON Pharmaceuticals Inc. (TCON) and Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) Comparing side by side - Stocks Beat
Posted: September 10th, 2019, 3:47pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) Comparing side by side Stocks BeatTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) compete with each other in the Biotechnology sector.
-
My Dad Was A 9/11 First Responder. Then A Giant Tumor Started Growing In His Chest. - HuffPost
Posted: September 10th, 2019, 3:12pm GMT
My Dad Was A 9/11 First Responder. Then A Giant Tumor Started Growing In His Chest. HuffPost9/11-related illnesses often make affected families feel like that dark day has never ended.
-
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$0.19 Per Share - Slater Sentinel
Posted: September 10th, 2019, 10:59pm GMT
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$0.19 Per Share Slater SentinelEquities analysts expect that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will report earnings per share of ($0.19) for the current fiscal quarter, Zacks reports ...
-
Orphan Drugs Market Analysis by Industry Value, Market Size, Top Companies and Growth Forecast - ScoopJunction
Posted: September 9th, 2019, 4:36pm GMT
Orphan Drugs Market Analysis by Industry Value, Market Size, Top Companies and Growth Forecast ScoopJunctionThe study provides detail insights about the manufacturers of the industry, regional/country level market size outlook, perceived the tendency of market, ...
-
Angiosarcoma- Pipeline Intelligence, 2019 Market Size 2019 Continues to Grow, Secures Top Tier Speakers - Technology Stats News
Posted: September 9th, 2019, 5:06am GMT
Angiosarcoma- Pipeline Intelligence, 2019 Market Size 2019 Continues to Grow, Secures Top Tier Speakers Technology Stats NewsAngiosarcoma- Pipeline Intelligence, 2019 Market research now available at Brand Essence Research encompasses an exhaustive Study of this business ...
-
Angiosarcoma- Pipeline Intelligence, 2019 Market Size 2019 Continues to Grow, Secures Top Tier Speakers - Industry Stats News
Posted: September 9th, 2019, 4:09am GMT
Angiosarcoma- Pipeline Intelligence, 2019 Market Size 2019 Continues to Grow, Secures Top Tier Speakers Industry Stats NewsAngiosarcoma- Pipeline Intelligence, 2019 Market research now available at Brand Essence Research encompasses an exhaustive Study of this business ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated at HC Wainwright - TechNewsObserver
Posted: September 7th, 2019, 1:24pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated at HC Wainwright TechNewsObserverHC Wainwright initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON) in a research note issued to investors on Thursday, August 29th, ...
-
What's Next for Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Having Less Shares Shorted? - Invest Tribune
Posted: September 7th, 2019, 12:53pm GMT
What's Next for Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Having Less Shares Shorted? Invest TribuneThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
Athenex, Inc. (ATNX) Reaches $14.19 After 5.00% Down Move; SANEI ARCHITECTURE PLANNING CO LTD TOKYO (SNHPF) Sellers Decreased By 14.29% Their Shorts - Stocks Beat
Posted: September 6th, 2019, 3:03pm GMT
Athenex, Inc. (ATNX) Reaches $14.19 After 5.00% Down Move; SANEI ARCHITECTURE PLANNING CO LTD TOKYO (SNHPF) Sellers Decreased By 14.29% Their Shorts Stocks BeatThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock decreased 3.14% or $0.46 during the last trading session, reaching $14.19.
-
'We still haven't found the right hero': A Pewaukee woman is searching for a living kidney donor for her husband - Milwaukee Journal Sentinel
Posted: September 6th, 2019, 12:42pm GMT
'We still haven't found the right hero': A Pewaukee woman is searching for a living kidney donor for her husband Milwaukee Journal SentinelHusband and wife Tom and Karen Buelow of Pewaukee have been married since 1986. In 2011, Tom was diagnosed with kidney disease, and is currently ...
-
Insider Buying: TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Buys 50000 Shares of Stock - Slater Sentinel
Posted: September 6th, 2019, 1:02am GMT
Insider Buying: TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Buys 50000 Shares of Stock Slater SentinelTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer bought 50000 shares of the firm's stock in a transaction that occurred on Friday, August ...
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Buys $22,500.00 in Stock - Mayfield Recorder
Posted: September 6th, 2019, 12:59am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Buys $22,500.00 in Stock Mayfield RecorderTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer bought 50000 shares of the firm's stock in a transaction that occurred on Friday, August ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Now Covered by HC Wainwright - Slater Sentinel
Posted: September 5th, 2019, 10:46am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Now Covered by HC Wainwright Slater SentinelHC Wainwright initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON) in a research note released on Thursday, August 29th, ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Now Covered by HC Wainwright - Slater Sentinel
Posted: September 5th, 2019, 10:46am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Now Covered by HC Wainwright Slater SentinelHC Wainwright initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON) in a research note released on Thursday, August 29th, ...
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Vaxart Inc. (NASDAQ:VXRT) - CryptoCoinsTribune
Posted: September 4th, 2019, 8:39pm GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Vaxart Inc. (NASDAQ:VXRT) CryptoCoinsTribuneTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Vaxart Inc. (NASDAQ:VXRT) have been rivals in the Biotechnology for quite some time. Below is a review ...
-
Insider Buying: TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Buys 50,000 Shares of Stock - Tech Know Bits
Posted: September 4th, 2019, 8:36pm GMT
Insider Buying: TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Buys 50,000 Shares of Stock Tech Know BitsTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer purchased 50000 shares of TRACON Pharmaceuticals stock in a transaction that ...
-
Athenex, Inc. (ATNX) Reaches $14.21 After 7.00% Down Move; HMN Financial (HMNF)'s Sentiment Is 3.33 - The NBO News
Posted: September 4th, 2019, 3:23pm GMT
Athenex, Inc. (ATNX) Reaches $14.21 After 7.00% Down Move; HMN Financial (HMNF)'s Sentiment Is 3.33 The NBO NewsThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock decreased 0.77% or $0.11 during the last trading session, reaching $14.21.
-
Count Me In launches Brain Cancer Project - PRNewswire
Posted: September 4th, 2019, 11:33am GMT
Count Me In launches Brain Cancer Project PRNewswireCAMBRIDGE, Mass., Sept. 4, 2019 /PRNewswire/ -- Count Me In, a non-profit research initiative, has launched the Brain Cancer Project ...
-
Count Me In launches Brain Cancer Project - P&T Community
Posted: September 4th, 2019, 11:33am GMT
Count Me In launches Brain Cancer Project P&T CommunityCAMBRIDGE, Mass., Sept. 4, 2019 /PRNewswire/ -- Count Me In, a non-profit research initiative, has launched the Brain Cancer Project ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Lowered to Sell at Zacks Investment Research - Sundance Herald
Posted: September 4th, 2019, 10:05am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Lowered to Sell at Zacks Investment Research Sundance HeraldZacks Investment Research lowered shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a hold rating to a sell rating in a research report sent to ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Lowered to Sell at Zacks Investment Research - Sundance Herald
Posted: September 4th, 2019, 10:05am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Lowered to Sell at Zacks Investment Research Sundance HeraldZacks Investment Research lowered shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a hold rating to a sell rating in a research report sent to ...
-
Angiosarcomas Treatment Market Analysis By Geography, Competitors, Trends and Demands To 2026 - News AIM
Posted: September 4th, 2019, 5:28am GMT
Angiosarcomas Treatment Market Analysis By Geography, Competitors, Trends and Demands To 2026 News AIMAngiosarcoma is a rare cancer of the inner lining of blood vessels, which occur in any area of the body, including the skin, breast, liver, spleen, and deep tissue ...
-
Celsion Corporation (CLSN)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - Stocks Beat
Posted: September 4th, 2019, 11:19pm GMT
Celsion Corporation (CLSN)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Stocks BeatCelsion Corporation (NASDAQ:CLSN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) have been rivals in the Biotechnology for quite some time. Below is ...
-
Dr. D'Angelo on Bempegaldesleukin/Nivolumab Combo in Sarcomas - OncLive
Posted: September 3rd, 2019, 5:22pm GMT
Dr. D'Angelo on Bempegaldesleukin/Nivolumab Combo in Sarcomas OncLiveSandra P. D'Angelo, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the results of a pilot study investigating the combination of ...
-
Literatus: Vape updates: Increases heart, lung disease risks - SunStar Philippines
Posted: September 3rd, 2019, 8:11am GMT
Literatus: Vape updates: Increases heart, lung disease risks SunStar PhilippinesAMERICAN author Mark Twain wrote: “Giving up smoking is the easiest thing in the world. I know because I've done it thousands of times.” Today, giving up ...
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Reports Decline in Sellers; Strong Momentum for Longs - Invest Tribune
Posted: September 2nd, 2019, 6:47pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Reports Decline in Sellers; Strong Momentum for Longs Invest TribuneThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Stock Is Buy After Less Market Selling - The MAK Daily
Posted: September 2nd, 2019, 5:40pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Stock Is Buy After Less Market Selling The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$0.19 Per Share - Slater Sentinel
Posted: September 2nd, 2019, 5:03am GMT
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$0.19 Per Share Slater SentinelEquities analysts expect that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will report earnings per share of ($0.19) for the current fiscal quarter, Zacks reports ...
-
TRACON Pharmaceuticals Inc. (TCON) and Biofrontera AG (NASDAQ:BFRA) Comparison side by side - The EN Herald
Posted: September 1st, 2019, 9:17pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Biofrontera AG (NASDAQ:BFRA) Comparison side by side The EN HeraldThis is a contrast between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Biofrontera AG (NASDAQ:BFRA) based on their analyst recommendations, ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Issues Earnings Results - Riverton Roll
Posted: September 1st, 2019, 11:58pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Issues Earnings Results Riverton RollTRACON Pharmaceuticals (NASDAQ:TCON) issued its quarterly earnings results on Wednesday, August 7th. The biopharmaceutical company reported ($0.21) ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated at HC Wainwright - TechNewsObserver
Posted: August 31st, 2019, 11:07am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated at HC Wainwright TechNewsObserverEquities researchers at HC Wainwright started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON) in a research note issued on Thursday, ...
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Stocks Beat
Posted: August 31st, 2019, 10:56pm GMT
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Stocks BeatWe will be contrasting the differences between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and DiaMedica Therapeutics Inc. (NASDAQ:DMAC) as far as ...
-
Athenex, Inc. (ATNX) Reaches $14.72 After 8.00% Down Move; 3M Co (MMM) Has 0.98 Sentiment - The EN Herald
Posted: August 30th, 2019, 4:43pm GMT
Athenex, Inc. (ATNX) Reaches $14.72 After 8.00% Down Move; 3M Co (MMM) Has 0.98 Sentiment The EN HeraldThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock decreased 3.66% or $0.56 during the last trading session, reaching $14.72.
-
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by Zacks Investment Research - Riverton Roll
Posted: August 30th, 2019, 8:36am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by Zacks Investment Research Riverton RollTRACON Pharmaceuticals (NASDAQ:TCON) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Puma Biotechnology Inc. (NASDAQ:PBYI)'s results - Stocks Beat
Posted: August 29th, 2019, 7:06pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Puma Biotechnology Inc. (NASDAQ:PBYI)'s results Stocks BeatBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Puma Biotechnology Inc. (NASDAQ:PBYI) compete on a level playing field in the Biotechnology ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Downgraded by Zacks Investment Research to “Sell” - TechNewsObserver
Posted: August 29th, 2019, 9:07am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Downgraded by Zacks Investment Research to “Sell” TechNewsObserverZacks Investment Research lowered shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a hold rating to a sell rating in a report issued on Wednesday ...
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Just Reported Decreased Shorts - The MAK Daily
Posted: August 28th, 2019, 8:07pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Just Reported Decreased Shorts The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Just Reported Decreased Shorts - The MAK Daily
Posted: August 28th, 2019, 8:07pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Just Reported Decreased Shorts The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
Leamington man with rare form of sarcoma cancer looking for new home - Leamington Courier
Posted: August 28th, 2019, 12:38pm GMT
Leamington man with rare form of sarcoma cancer looking for new home Leamington CourierA Leamington man with a rare form of sarcoma cancer is looking for a new home after he says damp wet conditions have left his current flat unsuitable for his ...
-
Angiosarcomas Treatment Market Analysis by Top Key Players and Overview 2024 - SocioHerald
Posted: August 28th, 2019, 9:20am GMT
Angiosarcomas Treatment Market Analysis by Top Key Players and Overview 2024 SocioHeraldRare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, ...
-
Angiosarcomas Treatment Market: Segmentation, Opportunities, Trends & Future Scope to 2024 - Market Reports
Posted: August 28th, 2019, 3:31am GMT
Angiosarcomas Treatment Market: Segmentation, Opportunities, Trends & Future Scope to 2024 Market ReportsRare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, ...
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Purchases 50,000 Shares - Sundance Herald
Posted: August 28th, 2019, 2:41am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Purchases 50,000 Shares Sundance HeraldTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer bought 50000 shares of the business's stock in a transaction on Friday, August 9th.
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Purchases 50000 Shares - Sundance Herald
Posted: August 28th, 2019, 2:41am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Purchases 50000 Shares Sundance HeraldTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer bought 50000 shares of the business's stock in a transaction on Friday, August 9th.
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Purchases $22,500.00 in Stock - Tech Know Bits
Posted: August 28th, 2019, 2:39am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Purchases $22,500.00 in Stock Tech Know BitsTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer acquired 50000 shares of the stock in a transaction dated Friday, August 9th. The stock ...
-
Former Tepcoglass President Bill Keen Dies at 64 - USGlass Metal & Glazing
Posted: August 27th, 2019, 8:18pm GMT
Former Tepcoglass President Bill Keen Dies at 64 USGlass Metal & GlazingBill Keen, former president and CEO of Tepcoglass, passed away on July 29, 2019 at the age of 64 after a battle with hepatic angiosarcoma. Keen was once a ...
-
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$0.19 Per Share - Slater Sentinel
Posted: August 25th, 2019, 11:08am GMT
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$0.19 Per Share Slater SentinelEquities analysts expect that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will report earnings per share of ($0.19) for the current fiscal quarter, Zacks reports ...
-
Yorktown Management & Research Co Has Upped Ares Commercial Real Estate Corp. (ACRE) Position By $525,000; Athenex (ATNX) Shorts Increased By 2.51% - CryptoCoinsTribune
Posted: August 24th, 2019, 5:38pm GMT
Yorktown Management & Research Co Has Upped Ares Commercial Real Estate Corp. (ACRE) Position By $525,000; Athenex (ATNX) Shorts Increased By 2.51% CryptoCoinsTribuneYorktown Management & Research Co Inc increased Ares Commercial Real Estate Corp. (ACRE) stake by 15.22% reported in 2019Q1 SEC filing. Yorktown ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Rating Lowered to Sell at Zacks Investment Research - Slater Sentinel
Posted: August 24th, 2019, 3:48pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Rating Lowered to Sell at Zacks Investment Research Slater SentinelTRACON Pharmaceuticals (NASDAQ:TCON) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors ...
-
Will Tracon Pharmaceuticals Inc (NASDAQ:TCON) Run Out of Steam Soon? Short Interest Is Down - The MAK Daily
Posted: August 24th, 2019, 11:44am GMT
Will Tracon Pharmaceuticals Inc (NASDAQ:TCON) Run Out of Steam Soon? Short Interest Is Down The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Earnings Results, Misses Expectations By $0.02 EPS - Slater Sentinel
Posted: August 24th, 2019, 6:10am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Earnings Results, Misses Expectations By $0.02 EPS Slater SentinelTRACON Pharmaceuticals (NASDAQ:TCON) announced its quarterly earnings results on Wednesday, August 7th. The biopharmaceutical company reported ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Earnings Results, Misses Expectations By $0.02 EPS - Slater Sentinel
Posted: August 24th, 2019, 6:10am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Earnings Results, Misses Expectations By $0.02 EPS Slater SentinelTRACON Pharmaceuticals (NASDAQ:TCON) announced its quarterly earnings results on Wednesday, August 7th. The biopharmaceutical company reported ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Lowered to Sell at Zacks Investment Research - Sundance Herald
Posted: August 23rd, 2019, 11:15am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Lowered to Sell at Zacks Investment Research Sundance HeraldZacks Investment Research lowered shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a hold rating to a sell rating in a research report sent to ...
-
Gidea Park family raises £100k for cancer charity in memory of daughter - Romford Recorder
Posted: August 23rd, 2019, 4:00am GMT
Gidea Park family raises £100k for cancer charity in memory of daughter Romford RecorderThe family of a woman who died from a rare form of cancer have raised £100000 for charity in her memory.
-
TRACON Pharmaceuticals Inc. (TCON) and Zosano Pharma Corporation (NASDAQ:ZSAN) Comparison side by side - Stocks Beat
Posted: August 23rd, 2019, 11:36pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Zosano Pharma Corporation (NASDAQ:ZSAN) Comparison side by side Stocks BeatAs Biotechnology companies, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Zosano Pharma Corporation (NASDAQ:ZSAN) are our subject to compare.
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Xenetic Biosciences Inc. (NASDAQ:XBIO) - The EN Herald
Posted: August 23rd, 2019, 10:52pm GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Xenetic Biosciences Inc. (NASDAQ:XBIO) The EN HeraldBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Xenetic Biosciences Inc. (NASDAQ:XBIO) are Biotechnology companies, competing one another.
-
TRACON Pharmaceuticals Inc. (TCON) and Aquestive Therapeutics Inc. (NASDAQ:AQST) Contrasting side by side - Stocks Beat
Posted: August 22nd, 2019, 9:28pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Aquestive Therapeutics Inc. (NASDAQ:AQST) Contrasting side by side Stocks BeatTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Aquestive Therapeutics Inc. (NASDAQ:AQST) compete against each other in the Biotechnology sector.
-
Heart Tumor Market 2019 – Global Industry Analysis, Segments, Industry News, Emerging Technologies, Major Geographies, Key Players and Current Industry Forecast 2023 - Press Release - Digital Journal
Posted: August 22nd, 2019, 10:32am GMT
Heart Tumor Market 2019 – Global Industry Analysis, Segments, Industry News, Emerging Technologies, Major Geographies, Key Players and Current Industry Forecast 2023 - Press Release Digital Journal“Global Heart Tumor Market” Report of Market Research Future (MRFR)'s Explores Scope of the Study as Research Objective, Assumptions and Limitations ...
-
Vinyl Chloride Monomer Market 2019-2025 Witness Substantially Owing to Rising Bu - ITResearchBrief.com
Posted: August 22nd, 2019, 5:00am GMT
Vinyl Chloride Monomer Market 2019-2025 Witness Substantially Owing to Rising Bu ITResearchBrief.comAsia Pacific is projected to be the major vinyl chloride monomer market due to high degree of industrialization and construction activities in Asia Pacific countries ...
-
Analyzing TRACON Pharmaceuticals (NASDAQ:TCON) & Gene Biotherapeutics (NASDAQ:CRXM) - Mayfield Recorder
Posted: August 22nd, 2019, 4:03am GMT
Analyzing TRACON Pharmaceuticals (NASDAQ:TCON) & Gene Biotherapeutics (NASDAQ:CRXM) Mayfield RecorderTRACON Pharmaceuticals (NASDAQ:TCON) and Gene Biotherapeutics (OTCMKTS:CRXM) are both small-cap medical companies, but which is the superior ...
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Acquires 50,000 Shares - Mayfield Recorder
Posted: August 21st, 2019, 12:57pm GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Acquires 50,000 Shares Mayfield RecorderTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer purchased 50000 shares of the firm's stock in a transaction on Friday, August 9th.
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Acquires 50000 Shares - Mayfield Recorder
Posted: August 21st, 2019, 12:57pm GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Acquires 50000 Shares Mayfield RecorderTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer purchased 50000 shares of the firm's stock in a transaction on Friday, August 9th.
-
Global Soft Tissue Sarcoma Market to Exhibit 8.2% CAGR by 2023, Increase Prevalence Rate Fueling the Demand for Soft Tissue Sarcoma Treatment - Press Release - Digital Journal
Posted: August 20th, 2019, 9:32pm GMT
Global Soft Tissue Sarcoma Market to Exhibit 8.2% CAGR by 2023, Increase Prevalence Rate Fueling the Demand for Soft Tissue Sarcoma Treatment - Press Release Digital JournalSoft Tissue Sarcoma Market 2019 Global Industry Analysis To 2023, is latest research report on Global Soft Tissue Sarcoma Industry Size, Share, Trends, ...
-
Osmotica Pharmaceuticals plc (OSMT)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - Stocks Beat
Posted: August 20th, 2019, 12:04pm GMT
Osmotica Pharmaceuticals plc (OSMT)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Stocks BeatOsmotica Pharmaceuticals plc (NASDAQ:OSMT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete with each other in the Biotechnology sector.
-
Angiosarcomas Treatment Market | Trends, Share, Growth Rate, Opportunities and Market Forecast 2016-2024 - TheSlapClap
Posted: August 20th, 2019, 11:11am GMT
Angiosarcomas Treatment Market | Trends, Share, Growth Rate, Opportunities and Market Forecast 2016-2024 TheSlapClapRare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, ...
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Purchases $22500.00 in Stock - Sundance Herald
Posted: August 20th, 2019, 8:41am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Purchases $22500.00 in Stock Sundance HeraldTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer bought 50000 shares of the firm's stock in a transaction on Friday, August 9th. The stock ...
-
Financial Comparison: TRACON Pharmaceuticals (NASDAQ:TCON) versus Idera Pharmaceuticals (NASDAQ:IDRA) - Sundance Herald
Posted: August 20th, 2019, 3:48am GMT
Financial Comparison: TRACON Pharmaceuticals (NASDAQ:TCON) versus Idera Pharmaceuticals (NASDAQ:IDRA) Sundance HeraldTRACON Pharmaceuticals (NASDAQ:TCON) and Idera Pharmaceuticals (NASDAQ:IDRA) are both small-cap medical companies, but which is the better ...
-
A 22-Year-Old Woman With Pain, Tenderness and Swelling in the Breast - Cancer Network
Posted: August 19th, 2019, 5:52pm GMT
A 22-Year-Old Woman With Pain, Tenderness and Swelling in the Breast cancernetwork.comA 22-year-old Caucasian woman presents with a four month history of pain, tenderness and swelling in her right breast. What's your diagnosis?
-
A 22-Year-Old Woman With Pain, Tenderness and Swelling in the Breast - Cancer Network
Posted: August 19th, 2019, 5:52pm GMT
A 22-Year-Old Woman With Pain, Tenderness and Swelling in the Breast Cancer NetworkA 22-year-old Caucasian woman presents with a four month history of pain, tenderness and swelling in her right breast. What's your diagnosis?
-
Oral Paclitaxel Combo Shows Higher Response Rate Than IV Paclitaxel in Breast Cancer - Specialty Pharmacy Times
Posted: August 19th, 2019, 2:15pm GMT
Oral Paclitaxel Combo Shows Higher Response Rate Than IV Paclitaxel in Breast Cancer Specialty Pharmacy TimesTreatment with oral paclitaxel and encequidar resulted in a statistically significant improvement in overall response rate (ORR) compared with intravenous (IV) ...
-
Angiosarcomas Treatment Market Effect and Growth Factors Research and Projection Till 2026 - Gazette Quest
Posted: August 19th, 2019, 11:19am GMT
Angiosarcomas Treatment Market Effect and Growth Factors Research and Projection Till 2026 Gazette QuestAngiosarcoma is a rare cancer of the inner lining of blood vessels, which occur in any area of the body, including the skin, breast, liver, spleen, and deep tissue ...
-
Cardiac Assist Devices Market Strategies and Forecasts, Overview And Companies By 2026 - Gazette Quest
Posted: August 19th, 2019, 11:19am GMT
Cardiac Assist Devices Market Strategies and Forecasts, Overview And Companies By 2026 Gazette QuestCardiac assist devices are mechanical pumps that assist the heart to enhance its pumping efficiency and help maintain optimal blood flow throughout the body.
-
Angiosarcomas Treatment Market Key Drivers & On-going Trends 2016 – 2024 - ScoopJunction
Posted: August 19th, 2019, 11:19am GMT
Angiosarcomas Treatment Market Key Drivers & On-going Trends 2016 – 2024 ScoopJunctionRare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, ...
-
What's Ahead for Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Less Shorted Shares? - Invest Tribune
Posted: August 18th, 2019, 7:33pm GMT
What's Ahead for Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Less Shorted Shares? Invest TribuneThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Stock Is Shorted Less - The MAK Daily
Posted: August 18th, 2019, 6:41pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Stock Is Shorted Less The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
TRACON Pharmaceuticals (NASDAQ:TCON) Cut to “Sell” at Zacks Investment Research - Mayfield Recorder
Posted: August 18th, 2019, 9:01am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Cut to “Sell” at Zacks Investment Research Mayfield RecorderZacks Investment Research lowered shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a hold rating to a sell rating in a report released on Thursday ...
-
Idera Pharmaceuticals (NASDAQ:IDRA) vs. TRACON Pharmaceuticals (NASDAQ:TCON) Head-To-Head Contrast - Mayfield Recorder
Posted: August 18th, 2019, 2:45am GMT
Idera Pharmaceuticals (NASDAQ:IDRA) vs. TRACON Pharmaceuticals (NASDAQ:TCON) Head-To-Head Contrast Mayfield RecorderIdera Pharmaceuticals (NASDAQ:IDRA) and TRACON Pharmaceuticals (NASDAQ:TCON) are both small-cap medical companies, but which is the superior ...
-
Zacks Investment Research Downgrades TRACON Pharmaceuticals (NASDAQ:TCON) to Sell - Sundance Herald
Posted: August 17th, 2019, 9:28am GMT
Zacks Investment Research Downgrades TRACON Pharmaceuticals (NASDAQ:TCON) to Sell Sundance HeraldTRACON Pharmaceuticals (NASDAQ:TCON) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to ...
-
Athenex, Inc. (ATNX) Reaches $15.47 After 9.00% Up Move; Bridgewater Associates LP Lowered Open Text (OTEX) Position - The EN Herald
Posted: August 16th, 2019, 2:44pm GMT
Athenex, Inc. (ATNX) Reaches $15.47 After 9.00% Up Move; Bridgewater Associates LP Lowered Open Text (OTEX) Position The EN HeraldBridgewater Associates Lp decreased Open Text Corp (OTEX) stake by 23.98% reported in 2019Q1 SEC filing. Bridgewater Associates Lp sold 20,028 shares ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Issues Earnings Results, Misses Expectations By $0.02 EPS - Sundance Herald
Posted: August 16th, 2019, 1:02pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Issues Earnings Results, Misses Expectations By $0.02 EPS Sundance HeraldTRACON Pharmaceuticals (NASDAQ:TCON) issued its quarterly earnings data on Wednesday, August 7th. The biopharmaceutical company reported ($0.21) ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - Riverton Roll
Posted: August 16th, 2019, 12:20pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS Riverton RollTRACON Pharmaceuticals (NASDAQ:TCON) issued its quarterly earnings data on Wednesday, August 7th. The biopharmaceutical company reported ($0.21) ...
-
TRACON Pharmaceuticals Inc. (TCON) and Catalyst Biosciences Inc. (NASDAQ:CBIO) Contrasting side by side - Stocks Beat
Posted: August 16th, 2019, 11:53pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Catalyst Biosciences Inc. (NASDAQ:CBIO) Contrasting side by side Stocks BeatAs Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Catalyst Biosciences Inc. (NASDAQ:CBIO), are affected by compare.
-
TRACON Pharmaceuticals Inc. (TCON) and Urovant Sciences Ltd. (NASDAQ:UROV) Comparing side by side - Stocks Beat
Posted: August 15th, 2019, 3:57pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Urovant Sciences Ltd. (NASDAQ:UROV) Comparing side by side Stocks BeatWe will be contrasting the differences between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Urovant Sciences Ltd. (NASDAQ:UROV) as far as ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Oragenics Inc. (NYSEAMERICAN:OGEN)'s results - Stocks Beat
Posted: August 15th, 2019, 11:39pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Oragenics Inc. (NYSEAMERICAN:OGEN)'s results Stocks BeatTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Oragenics Inc. (NYSEAMERICAN:OGEN) have been rivals in the Biotechnology for quite some time.
-
Athenex, Inc. (ATNX) Reaches $15.07 After 5.00% Up Move; Crescent Park Management LP Has Trimmed Td Ameritrade Hldg (AMTD) Stake - Stocks Beat
Posted: August 14th, 2019, 1:32pm GMT
Athenex, Inc. (ATNX) Reaches $15.07 After 5.00% Up Move; Crescent Park Management LP Has Trimmed Td Ameritrade Hldg (AMTD) Stake Stocks BeatThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock increased 1.79% or $0.26 during the last trading session, reaching $15.07.
-
Charles Theuer Purchases 50,000 Shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) Stock - Mayfield Recorder
Posted: August 14th, 2019, 12:51pm GMT
Charles Theuer Purchases 50,000 Shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) Stock Mayfield RecorderTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer purchased 50000 shares of TRACON Pharmaceuticals stock in a transaction on Friday, ...
-
Charles Theuer Purchases 50,000 Shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) Stock - Riverton Roll
Posted: August 14th, 2019, 12:50pm GMT
Charles Theuer Purchases 50,000 Shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) Stock Riverton RollTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer purchased 50000 shares of the company's stock in a transaction that occurred on ...
-
What Will Happen to Tracon Pharmaceuticals Inc (NASDAQ:TCON) Next? The Stock Has Decline in Shorts - The MAK Daily
Posted: August 13th, 2019, 2:23pm GMT
What Will Happen to Tracon Pharmaceuticals Inc (NASDAQ:TCON) Next? The Stock Has Decline in Shorts The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
What's in Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Decline in Shorted Shares? - The Altcoin Mercury
Posted: August 13th, 2019, 1:40pm GMT
What's in Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Decline in Shorted Shares? The Altcoin MercuryThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Buys 50,000 Shares - Tech Know Bits
Posted: August 13th, 2019, 8:35am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Buys 50,000 Shares Tech Know BitsTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer purchased 50000 shares of TRACON Pharmaceuticals stock in a transaction dated ...
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Buys 50,000 Shares - Sundance Herald
Posted: August 13th, 2019, 8:33am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Insider Charles Theuer Buys 50,000 Shares Sundance HeraldTRACON Pharmaceuticals Inc (NASDAQ:TCON) insider Charles Theuer purchased 50000 shares of TRACON Pharmaceuticals stock in a transaction dated ...
-
Angiosarcomas Treatment Market 2026 Application, Consumption, Market Share, Growth Opportunities, Regions - Business Intelligence
Posted: August 13th, 2019, 4:29am GMT
Angiosarcomas Treatment Market 2026 Application, Consumption, Market Share, Growth Opportunities, Regions Business IntelligenceAngiosarcoma is a rare cancer of the inner lining of blood vessels, which occur in any area of the body, including the skin, breast, liver, spleen, and deep tissue ...
-
Head-To-Head Review: Idera Pharmaceuticals (NASDAQ:IDRA) vs. TRACON Pharmaceuticals (NASDAQ:TCON) - Tech Know Bits
Posted: August 12th, 2019, 11:39am GMT
Head-To-Head Review: Idera Pharmaceuticals (NASDAQ:IDRA) vs. TRACON Pharmaceuticals (NASDAQ:TCON) Tech Know BitsIdera Pharmaceuticals (NASDAQ:IDRA) and TRACON Pharmaceuticals (NASDAQ:TCON) are both small-cap medical companies, but which is the better ...